OppenheimerFunds Inc. boosted its position in shares of CryoPort Inc (NASDAQ:CYRX) by 4.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 426,735 shares of the consumer goods maker’s stock after buying an additional 16,904 shares during the quarter. OppenheimerFunds Inc. owned approximately 1.55% of CryoPort worth $6,734,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Citadel Advisors LLC bought a new stake in shares of CryoPort in the 2nd quarter valued at $307,000. BlackRock Inc. increased its holdings in CryoPort by 507.7% during the 2nd quarter. BlackRock Inc. now owns 1,745,626 shares of the consumer goods maker’s stock worth $27,545,000 after purchasing an additional 1,458,357 shares in the last quarter. Schwab Charles Investment Management Inc. bought a new position in CryoPort during the 2nd quarter worth about $864,000. Monarch Partners Asset Management LLC increased its holdings in CryoPort by 39.9% during the 2nd quarter. Monarch Partners Asset Management LLC now owns 40,180 shares of the consumer goods maker’s stock worth $634,000 after purchasing an additional 11,450 shares in the last quarter. Finally, Greenwood Capital Associates LLC bought a new position in CryoPort during the 2nd quarter worth about $163,000. 48.53% of the stock is currently owned by hedge funds and other institutional investors.

CYRX has been the subject of a number of recent research reports. B. Riley initiated coverage on shares of CryoPort in a research note on Wednesday. They set a “buy” rating and a $22.00 price objective for the company. BidaskClub downgraded shares of CryoPort from a “buy” rating to a “hold” rating in a research note on Wednesday, September 26th. Cowen raised their target price on shares of CryoPort from $11.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday, August 13th. Needham & Company LLC raised their target price on shares of CryoPort from $11.00 to $19.00 and gave the company a “buy” rating in a research note on Monday, July 2nd. Finally, Roth Capital increased their price target on shares of CryoPort from $12.50 to $22.00 and gave the company a “buy” rating in a report on Friday, June 29th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. CryoPort presently has a consensus rating of “Buy” and a consensus price target of $19.75.

Shares of CYRX traded down $0.09 during mid-day trading on Friday, hitting $11.52. 171,706 shares of the company’s stock were exchanged, compared to its average volume of 277,773. The stock has a market capitalization of $367.59 million, a PE ratio of -33.88 and a beta of 1.11. CryoPort Inc has a 52 week low of $6.02 and a 52 week high of $16.88.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings data on Thursday, August 9th. The consumer goods maker reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). The firm had revenue of $4.63 million during the quarter, compared to the consensus estimate of $4.36 million. CryoPort had a negative net margin of 62.80% and a negative return on equity of 45.60%. CryoPort’s revenue for the quarter was up 58.6% compared to the same quarter last year. As a group, sell-side analysts forecast that CryoPort Inc will post -0.34 EPS for the current year.

In other news, CEO Richard J. Berman sold 20,000 shares of CryoPort stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $12.81, for a total transaction of $256,200.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard J. Berman sold 10,000 shares of CryoPort stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $14.00, for a total transaction of $140,000.00. The disclosure for this sale can be found here. Company insiders own 9.60% of the company’s stock.

CryoPort Company Profile

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Read More: How Important is Technical Analysis of Stocks

Institutional Ownership by Quarter for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.